نتایج جستجو برای: bortezomib microscopy ovariectomy rat stereology

تعداد نتایج: 470039  

2016
Shardule P. Shah Ajay K. Nooka David L. Jaye Nizar J. Bahlis Sagar Lonial Lawrence H. Boise

Proteasome inhibitors such as bortezomib are highly active in multiple myeloma by affecting signaling cascades and leading to a toxic buildup of misfolded proteins. Bortezomib-treated cells activate the cytoprotective heat shock response (HSR), including upregulation of heat shock proteins (HSPs). Here we inhibited the bortezomib-induced HSR by silencing its master regulator, Heat Shock Factor ...

2012
Deborah J. Kuhn Zuzana Berkova Richard J. Jones Richard Woessner Chad C. Bjorklund Wencai Ma R. Eric Davis Pei Lin Hua Wang Timothy L. Madden Caimiao Wei Veerabhadran Baladandayuthapani Michael Wang Sheeba K. Thomas Jatin J. Shah Donna M. Weber Robert Z. Orlowski

Proteasome inhibition with bortezomib is a validated approach to the treatment of multiple myeloma, but drug resistance often emerges and limits its utility in the retreatment setting. To begin to identify some of the mechanisms involved, we developed bortezomib-resistant myeloma cell lines that, unlike previously reported models, showed no 5 subunit mutations. Instead, up-regulation of the ins...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2005
Vinita Uttamsingh Chuang Lu Gerald Miwa Liang-Shang Gan

VELCADE (bortezomib, PS-341), reversibly inhibits the 20S proteasome and exhibits cytotoxic and antitumor activities. Pretreatment of cancer cells with bortezomib increases the chemosensitivity of these cells, suggesting that bortezomib may be used in combination chemotherapy. The relative contributions of the five major human cytochromes P450 (P450s), 1A2, 2C9, 2C19, 2D6, and 3A4 (the focus of...

Journal: :Swiss medical weekly 2012
Christian Taverna Jerôme Voegeli Andreas Trojan Robert A Olie Albert von Rohr

Previous studies have shown that retreatment of relapsed/refractory multiple myeloma (MM) with a second course of bortezomib therapy could be effective in heavily pre-treated patients. In this study, the results of a multicentre, retrospective survey were reported involving patients in Switzerland with MM who responded to initial bortezomib therapy; 43 patients were enrolled and 42 were evaluat...

Journal: :Advances in Applied Probability 2013

Journal: :European Respiratory Review 2006

Journal: :Bosnian journal of basic medical sciences 2015
Ljiljana Šerman Iris Žunić Nina Vrsaljko Đurđica Grbeša Emil Gjurčević Željka Matašin Tamara Nikuševa Martić Floriana Bulić Jakuš Ivana Tlak Gajger Alan Šerman

Dear Editor, We are thankful to our colleagues for their interest in our paper and comments that they have provided. We could not agree more with the part of the letter regarding the method of sampling. On the basis of our 16-year-long experience in research on rat placentas, we underline sampling as one of the most important concepts in stereology, especially in the light of biological variabi...

2016
Daniel B. Hoffmann Markus H. Griesel Bastian Brockhusen Mohammad Tezval Marina Komrakova Bjoern Menger Marco Wassmann Klaus Michael Stuermer Stephan Sehmisch

Background. 8-Prenylnaringenin (8-PN) is the phytoestrogen with the highest affinity for estrogen receptor-α (ER-α), which is required to maintain BMD. The osteoprotective properties of 8-PN have been demonstrated previously in tibiae. We used a rat osteopenia model to perform the first investigation of 8-PN with whole-body vertical vibration (WBVV). Study Design. Ovariectomy was performed on 5...

Journal: :The American journal of physiology 1964
N B SCHWARTZ

207(6): rqv-1259. Ig64.In the cyclic rat, uterine weight increases at proestrus, pituitary LH content drops from a maximum at proestrus to a minimum at estrus, and ovulation and vaginal cornification then occur. To investigate the timing of the ovarian secretion presumably responsible for these changes, ovariectomy or sham ovariectomy was performed at increasing intervals before the day of estr...

Journal: :Haematologica 2015
Meletios A Dimopoulos Robert Z Orlowski Thierry Facon Pieter Sonneveld Kenneth C Anderson Meral Beksac Lotfi Benboubker Huw Roddie Anna Potamianou Catherine Couturier Huaibao Feng Ozlem Ataman Helgi van de Velde Paul G Richardson

Bortezomib-dexamethasone is widely used for relapsed myeloma in routine clinical practice, but comparative data versus single-agent bortezomib are lacking. This retrospective analysis compared second-line treatment with bortezomib-dexamethasone and bortezomib using 109 propensity score-matched pairs of patients treated in three clinical trials: MMY-2045, APEX, and DOXIL-MMY-3001. Propensity sco...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید